CD30-dependent_JJ
degradation_NN
of_IN
TRAF2_NN
:_:
implications_NNS
for_IN
negative_JJ
regulation_NN
of_IN
TRAF_NN
signaling_NN
and_CC
the_DT
control_NN
of_IN
cell_NN
survival_NN
._.

CD30_NN
is_VBZ
a_DT
cell-surface_JJ
receptor_NN
that_WDT
can_MD
augment_VB
lymphocyte_NN
activation_NN
and_CC
survival_NN
through_IN
its_PRP$
ability_NN
to_TO
induce_VB
the_DT
transcription_NN
factor_NN
NF-kappaB_NN
._.

CD30_NN
,_,
however_RB
,_,
has_VBZ
also_RB
been_VBN
implicated_VBN
in_IN
the_DT
induction_NN
of_IN
apoptotic_JJ
cell_NN
death_NN
of_IN
lymphocytes_NNS
._.

Here_RB
we_PRP
show_VBP
that_IN
one_CD
of_IN
the_DT
effects_NNS
of_IN
CD30_NN
signal_NN
transduction_NN
is_VBZ
to_TO
render_VB
cells_NNS
sensitive_JJ
to_TO
apoptosis_NN
induced_VBN
by_IN
the_DT
type_NN
1_CD
tumor_NN
necrosis_NN
factor_NN
receptor_NN
-LRB-_-LRB-
TNFR1_NN
-RRB-_-RRB-
._.

This_DT
sensitization_NN
is_VBZ
dependent_JJ
on_IN
the_DT
TRAF-binding_JJ
sites_NNS
within_IN
the_DT
CD30_NN
cytoplasmic_JJ
domain_NN
._.

One_CD
of_IN
the_DT
proteins_NNS
that_WDT
binds_VBZ
to_TO
these_DT
sites_NNS
is_VBZ
TRAF2_NN
,_,
a_DT
signal_NN
transduction_NN
molecule_NN
that_WDT
is_VBZ
also_RB
utilized_VBN
by_IN
TNFR1_NN
to_TO
mediate_VB
the_DT
activation_NN
of_IN
several_JJ
downstream_JJ
kinases_NNS
and_CC
transcription_NN
factors_NNS
._.

During_IN
CD30_NN
signal_NN
transduction_NN
,_,
we_PRP
found_VBD
that_IN
binding_NN
of_IN
TRAF2_NN
to_TO
the_DT
cytoplasmic_JJ
domain_NN
of_IN
CD30_NN
results_VBZ
in_IN
the_DT
rapid_JJ
depletion_NN
of_IN
TRAF2_NN
and_CC
the_DT
associated_JJ
protein_NN
TRAF1_NN
by_IN
proteolysis_NN
._.

These_DT
data_NNS
suggest_VBP
a_DT
model_NN
in_IN
which_WDT
CD30_NN
limits_VBZ
its_PRP$
own_JJ
ability_NN
to_TO
transduce_VB
cell_NN
survival_NN
signals_NNS
through_IN
signal-coupled_JJ
depletion_NN
of_IN
TRAF2_NN
._.

Depletion_NN
of_IN
intracellular_JJ
TRAF2_NN
and_CC
its_PRP$
coassociated_JJ
proteins_NNS
also_RB
increased_VBD
the_DT
sensitivity_NN
of_IN
the_DT
cell_NN
to_TO
undergoing_VBG
apoptosis_NN
during_IN
activation_NN
of_IN
death-inducing_JJ
receptors_NNS
such_JJ
as_IN
TNFR1_NN
._.

Consistent_JJ
with_IN
this_DT
hypothesis_NN
,_,
expression_NN
of_IN
a_DT
dominant-negative_JJ
form_NN
of_IN
TRAF2_NN
was_VBD
found_VBN
to_TO
potentiate_VB
TNFR1-mediated_JJ
death_NN
._.

These_DT
studies_NNS
provide_VBP
a_DT
potential_JJ
mechanism_NN
through_IN
which_WDT
CD30_NN
,_,
as_RB
well_RB
as_IN
other_JJ
TRAF-binding_JJ
members_NNS
of_IN
the_DT
TNFR_NN
superfamily_NN
,_,
can_MD
negatively_RB
regulate_VB
cell_NN
survival_NN
._.

